The Johns Hopkins Carey Business School is offering a unique opportunity for graduate students, postdoctoral fellows and medical residents interested in healthcare innovation and entrepreneurship. Selected applicants will participate in a 16-week course with full-time MBA students in designing and commercializing high-impact innovations. You will benefit from lectures, immersive team fieldwork to gain hands-on, data-driven experience innovating commercialize solutions that improve patients' health outcomes. The course runs from August 30, 2021 – December 20, 2021. Successful applicants should expect to commit 10 hours a week for 16 weeks, including full attendance of class sessions (Monday 8:30 a.m. – 11:30 a.m. OR 1:30 p.m. – 4:30 p.m.), virtually or in-person at Carey’s Harbor East campus. Participants will receive a certificate of completion from the Carey Business School. This program is free to fulltime students and postdocs at Johns Hopkins. It may be reimbursable under the employee benefit plan for trainees. This 2-part program consists of:
This 8-week experience is focused on developing healthcare related products or services. Students will learn from leading experts, identify unmet needs through field research and develop product or service design ideas. Students will apply human centered design thinking principles to develop prototypes for further validating in part 2 of the course.
Part 2 of this course will teach students the basic tools and skills needed to commercialize healthcare inventions. Taking the prototypes in from Design Lab, students will assess the intellectual property landscape and design approaches to protect their ideas. Students will develop go-to-market strategies for their innovations, learn to assess and financially model the business value of their prototypes, pitch their ideas, and create financing strategies with mentoring from industry experts.
Interested students and fellows should complete this application form by June 30, 2021. We will inform selected participants by July 15, 2021.
Please reach out to Supriya Munshaw or Phil Phan for any questions or concerns.